MS-NEUROPLAST: Neuroplasticity of Cortical Areas Induced by Cognitive Training in Patients with Multiple Sclerosis

NCT ID: NCT04806568

Last Updated: 2024-11-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

180 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-12-01

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This clinical study aims to identify MS related beneficial plasticity and by contrast maladaptive reorganization in combination with elements of daily functional status as a response to a cognitive training program

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Cognitive decline is a debilitating and widespread comorbidity of Multiple Sclerosis (MS) affecting up to 65 percent of patients with MS (PwMS). Cognitive changes can be the only behavioral index of MS activity. But how accurately and timely can these be captured? The existing clinical tools are subjective and do not have the dynamic of prognosis. It remains uncertain how much change in cognitive status is required to translate into a meaningful clinical outcome and how long it may subsequently take to become apparent. Moving towards a holistic approach, MS-NEUROPLAST aims to further expand previously-published prognostic marker candidates and previous work of the applicant and the members of the research team and employ a group of methodologies for interventions and applications which will quantify via real-world assessment the MS-related cognitive changes in order to characterize not only decline but given the right dosage of stimulation improvement as well.

MS-NEUROPLAST has three main objectives:

(i) Utilize state of-the-art neuroimaging and network science measures to more thoroughly understand neural indices of cognitive impairment in PwMS.

(ii) Evaluate the efficacy for treating MS-associated cognitive deficits using a computerized cognitive training treatment by determining the differences, between subjects treated with cognitive training and controls, on network science measures indexing network efficiency or collapse and on the performance of a battery of neuropsychological tests that are frequently impaired in MS.

(iii) Investigate the dissociation of the cortical mechanisms related to training-induced plasticity and maladaptive reorganization (namely separate good from bad), by taking into account the homeostatic capacity of the human organism as a whole and thus examining whether the correlation of the neurophysiological and cognitive indices with longitudinal digital biomarkers of daily functional status can capture the underlying pathology.

MS-NEUROPLAST stages for PwMS

1. Provide signed informed consent to participate in the study after being informed by the principal investigator.
2. Neurological evaluation and decision on whether the inclusion criteria are met.
3. The participants will visit the Medical Physics \& Digital Innovation Lab at AUTH, where:

A. They will undergo a neuropsychological and somatometric assessment

B. Then, they will undergo an electroencephalogram (EEG) measurement which includes the following:
* Placement of the EEG cap holding the electrodes on the head to record the electrical activity of the brain. The cap will be soaked with potassium chloride solution to maintain the electrodes' resistance at desired levels
* Wear over ear headphones
* Recording EEG activity at rest for 15 minutes with eyes closed
* View and listen to a series of simple images and sounds in video format and parallel recording of EEG evoked potentials using a complex eccentric (oddball) protocol combining multisensory audiovisual mismatches with unisensory acoustic and visual deviancies. Concurrently to the EEG measurements the subjects will respond behaviourally via button presses to an audiovisual congruency task on which they have to evaluate whether the images presented correspond to the tones they hear based on the rule: "the higher the pitch of the tone the higher the position of the circle". The recording will be performed 4 times, will include 32 sequences from each category audiovisual congruent, audiovisual incongruent, auditory deviant and visual deviant) resulting in 128 measurements from each condition for each participant. The measurement will take about 45 minutes.

C. Familiarization with using a personal computer or a tablet, and demonstration of both the BrainHQ environment for cognitive training and the wearable and ambient devices.
4. Use of a set of smart sensors to collect biomarkers (steps, calories, sleep duration, heart rate, oxygen saturation) of daily activities for a period of up to 1 month (at least 2 weeks) before the onset of cognitive training. This will be followed by cognitive training through BrainHQ exercises. The training should be performed with a frequency of at least 3 times a week, for about 60 minutes (30 minutes of pure practice), lasting up to 12 weeks. Adherence will be recorded by the BrainHQ application and any deviations from the schedule will be followed by communication via the telephone or in person aimed at mobilizing and re engaging participants. During cognitive training, the recording of biomarkers of daily activities will continue.
5. At the end of the training, stages 3A and 3B will be repeated.

MS-NEUROPLAST stages for Healthy Controls

1. Provide signed informed consent to participate in the study after being informed by the principal investigator
2. The participants will visit the Medical Physics \& Digital Innovation Lab at AUTH, where:

A. They will undergo a neuropsychological and somatometric assessment

B. Then, they will undergo an electroencephalogram (EEG) measurement which includes the following:

* Placement of the EEG cap holding the electrodes on the head to record the electrical activity of the brain. The cap will be soaked with potassium chloride solution to maintain the electrodes' resistance at desired levels
* Wear over ear headphones
* Recording EEG activity at rest for 15 minutes with eyes closed
* View and listen to a series of simple images and sounds in video format and parallel recording of EEG evoked potentials using a complex eccentric (oddball) protocol combining multisensory audiovisual mismatches with unisensory acoustic and visual deviancies. Concurrently to the EEG measurements the subjects will respond behaviourally via button presses to an audiovisual congruency task on which they have to evaluate whether the images presented correspond to the tones they hear based on the rule: "the higher the pitch of the tone the higher the position of the circle". The recording will be performed 4 times, will include 32 sequences from each category audiovisual congruent, audiovisual incongruent, auditory deviant and visual deviant) resulting in 128 measurements from each condition for each participant. The measurement will take about 45 minutes.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Multiple Sclerosis Cognitive Decline

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Patients will wear a smartwatch and will be randomly assigned to either the cognitive intervention, or the active control group, stratified by age, sex, education and cognition.
Primary Study Purpose

OTHER

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

PwMS-CCT

Adult individuals with Multiple Sclerosis will follow a cognitive training intervention.

* Neurological assessment

* History of Multiple Sclerosis
* Expanded Disability Status Scale (EDSS)
* 2 types of high-density electroencephalographic recordings

* at rest with eyes closed (15 minutes)
* event potentials via a multisensory oddball paradigm (45 minutes)
* Neuropsychological assessment

* MMSE
* CDT
* GVLT
* BVMT
* SDMT
* Verbal Fluency: Phonemic \[ Chi-Sigma-Alpha\] and Semantic \[Animals-Fruits-Objects\]
* Digit Span (For-Back-Seq)\_WAIS-4GR
* SNST
* GAT
* DASS21
* MSIS-29
* CRIq
* MFIS
* EQ-5D-5L
* BDI-II
* Somatometric assessment

* Timed 25-Foot Walk (T25-FW)
* 3m backwards walk test
* Hole Peg Test (9-HPT)
* Handgrip Strength Test
* Single Leg Stance (SLS)
* Four Square Step Test (FSST)
* BrainHQ training
* Monitoring of daily activity

Group Type EXPERIMENTAL

Cognitive Training

Intervention Type OTHER

The cognitive training treatment is a Greek adaptation of BrainHQ developed by Posit Science Corporation. The intervention will target speed, attention, working memory, and executive function through the visual and auditory domains via a set of 15 exercises. Each daily training session consists of four exercises chosen from an active set of six. Participants will be instructed to train for one hour per day, three days per week, over 12 weeks via a tablet. Each subject will receive at least 29 sessions of computerized cognitive training.

Monitoring of daily activity

Intervention Type DEVICE

Monitoring of daily activity via Fitbit Charge 4 smartwatch.

PwMS-CON

Adult individuals with Multiple Sclerosis serving as active controls.

* Neurological assessment

* History of Multiple Sclerosis
* Expanded Disability Status Scale (EDSS)
* 2 types of high-density electroencephalographic recordings

* at rest with eyes closed (15 minutes)
* event potentials via a multisensory oddball paradigm (45 minutes)
* Neuropsychological assessment

* Mini Mental Status Examination (MMSE)
* Clock Drawing Test (CDT)
* Greek Verbal Learning Test (GVLT)
* Brief Visuospatial Memory Test (BVMT)
* Symbol Digit Modalities Test (SDMT)
* Verbal Fluency: Phonemic \[ Chi-Sigma-Alpha\] and Semantic \[Animals-Fruits-Objects\]
* Digit Span (For-Back-Seq)\_WAIS-4GR
* Stroop Neuropsychological Test (SNST)
* The Greek Accentuation Test (GAT)
* DASS-21
* MSIS-29
* CRIq
* MFIS
* EQ-5D-5L
* BDI-II
* Somatometric assessment

* T25-FW
* 3m backwards walk test
* 9-HPT
* Handgrip Strength Test
* SLS
* FSST
* Monitoring of dailty activity

Group Type ACTIVE_COMPARATOR

Monitoring of daily activity

Intervention Type DEVICE

Monitoring of daily activity via Fitbit Charge 4 smartwatch.

HC

Healthy adults serving as passive controls.

* 2 types of high-density electroencephalographic recordings

* at rest with eyes closed (15 minutes)
* event potentials via a multisensory oddball paradigm (45 minutes)
* Neuropsychological assessment

* Mini Mental Status Examination (MMSE)
* Greek Verbal Learning Test (GVLT)
* Brief Visuospatial Memory Test (BVMT)
* Symbol Digit Modalities Test (SDMT)
* Somatometric assessment

* Timed 25-Foot Walk (T25-FW)
* 3m backwards walk test
* Hole Peg Test (9-HPT)
* Handgrip Strength Test
* Single Leg Stance (SLS)
* Four Square Step Test (FSST)

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Cognitive Training

The cognitive training treatment is a Greek adaptation of BrainHQ developed by Posit Science Corporation. The intervention will target speed, attention, working memory, and executive function through the visual and auditory domains via a set of 15 exercises. Each daily training session consists of four exercises chosen from an active set of six. Participants will be instructed to train for one hour per day, three days per week, over 12 weeks via a tablet. Each subject will receive at least 29 sessions of computerized cognitive training.

Intervention Type OTHER

Monitoring of daily activity

Monitoring of daily activity via Fitbit Charge 4 smartwatch.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male/female patients aged 18 to 65 years at screening
* Diagnosis of MS according to the 2017 Revised McDonald criteria
* Disability status at screening with an EDSS score of 0 to 6.5
* Relapsing MS and progressive MS as defined by Lublin
* Neurologically stable within 1 month prior to screening
* Patients receiving the same Disease Modifying Treatment (DMT) for at least 6 months


• Normal hearing and normal or corrected-to-normal vision

Exclusion Criteria

* Patients suspected of not being able or willing to cooperate or comply with study protocol requirements
* Patients meeting criteria for other demyelinating diseases of the CNS
* Patients with active chronic disease (or stable but treated with immune therapy) of the immune system other than MS
* Patients with any other significant CNS disease or serious psychiatric disorder which can interfere with the patient's ability to cooperate or comply with the study procedure
* Patients unable or unwilling to undergo MRI scans and EEG


* Any diagnosed neurological, mental, developmental, or psychiatric disorder
* Unrecovered neurological disorders (i.e., stroke, traumatic brain injury)
* Unstable medication within the last 3 months
* Intake of central nervous drugs (e.g., antidepressants)
* Severe physical disorder
* Concurrent participation in another relevant study
* Patients unable or unwilling to undergo EEG measurements
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

King Fahad Medical City

OTHER_GOV

Sponsor Role collaborator

Aristotle University Of Thessaloniki

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Panos Bamidis

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Charis Styliadis, PhD

Role: PRINCIPAL_INVESTIGATOR

Aristotle University Of Thessaloniki

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Laboratory of Medical Physics and Digital Innovation, AUTH

Thessaloniki, Central Macedonia, Greece

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Greece

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Charis Styliadis, PhD

Role: CONTACT

6942618582 ext. +30

Panagiotis D Bamidis, PhD

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Charis Styliadis, PhD

Role: primary

6942618582

Panagiotis D Bamidis, PhD

Role: backup

Nikolaos Grigoriadis, PhD

Role: backup

Vahe Poghosyan, PhD

Role: backup

Ioannis Nikolaidis, PhD

Role: backup

Antonis Billis, PhD

Role: backup

Vasiliki Zilidou, PhD

Role: backup

Panagiotis Kartsidis, MSc

Role: backup

Alexandra Anagnostopoulou, MSc

Role: backup

References

Explore related publications, articles, or registry entries linked to this study.

Styliadis C, Kartsidis P, Paraskevopoulos E, Ioannides AA, Bamidis PD. Neuroplastic effects of combined computerized physical and cognitive training in elderly individuals at risk for dementia: an eLORETA controlled study on resting states. Neural Plast. 2015;2015:172192. doi: 10.1155/2015/172192. Epub 2015 Apr 7.

Reference Type BACKGROUND
PMID: 25945260 (View on PubMed)

Klados MA, Styliadis C, Frantzidis CA, Paraskevopoulos E, Bamidis PD. Beta-Band Functional Connectivity is Reorganized in Mild Cognitive Impairment after Combined Computerized Physical and Cognitive Training. Front Neurosci. 2016 Feb 29;10:55. doi: 10.3389/fnins.2016.00055. eCollection 2016.

Reference Type BACKGROUND
PMID: 26973445 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

98223

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Emotions in Multiple Sclerosis
NCT04804787 COMPLETED NA